CBC vs CBD: How They Compare

CBD and CBC come from the same plant and neither gets you high, but they differ in prominence and mechanism. CBD, cannabidiol, is one of hemp’s most plentiful cannabinoids and is used for many goals, from anxiety to recovery to general calm. CBC, cannabichromene, is a minor cannabinoid present in much smaller amounts, and rather than acting on the CB1 receptor it engages the body’s TRP channels, which are involved in pain and temperature sensing, a mechanism mapped in the Journal of Pharmacology and Experimental Therapeutics. That gives it a different research profile focused on discomfort, mood, and inflammation.

In practice, you will find CBD sold on its own in gummies, oils, and tinctures, while CBC most often shows up as one of several cannabinoids in a full-spectrum product, where it contributes to the entourage effect rather than being taken alone. If you want a proven, versatile daily cannabinoid, CBD is the pick; CBC is more of a supporting compound whose benefits are still being studied. For how CBC compares to another minor cannabinoid, see CBC vs CBG.

Two of our CBD gummy formulas pair CBD with CBC: Stress and Libido Lift.

CBC vs CBD at a glance

Short version: CBD has the human research, and CBC has the interesting lab data. Here’s how they line up.

That trial gap is the single biggest difference. Everything we know about CBC comes from animal and cell studies (Sepulveda et al. 2024, in the Journal of Pharmacology and Experimental Therapeutics, called its potential “promising” while saying human studies are still needed). That doesn’t make CBC a dud. It means any CBC choice comes with an evidence caveat that CBD doesn’t carry to the same degree.

The one study that tested CBC and CBD head to head

Only one published study has compared CBC alone, CBD alone and the two together. Grogan and colleagues ran it in 2023 (Annals of Plastic Surgery, PMID 37332213) using mice with collagen-induced arthritis.

• CBC alone: no standalone drop in paw swelling compared with control
• CBD alone: no significant drop in swelling compared with control
• CBC plus CBD: a significant drop in swelling between weeks 3 and 5, beating either one alone

Real talk: this was 35 mice, not people, and no human trial has confirmed it. Still, it’s the closest thing to a direct CBC vs CBD answer, and it points toward pairing them rather than picking one.

Which should you use, CBC or CBD?

Start with CBD if you’re new to cannabinoids. It has the most human research, the deepest safety data and a lower cost per mg. Then match the rest to your goal:

• Choose CBD if your goal is calm, sleep or general wellness, or you want the most studied option.
• Choose CBC if you’re curious about its TRPA1 pain and inflammation research or a skin use, and you’re fine with the “no human trials yet” caveat.
• Combine them if your goal is inflammation related. That’s the pattern the Grogan 2023 study supports.
• Talk to your doctor first if you take prescription medications or your condition already has a proven treatment. Neither one replaces it.

Skin and acne, where CBC has an edge

This is one area where CBC has more targeted research than CBD. In Oláh et al. 2016 (PMID 27094344), researchers tested several cannabinoids on human sebocytes, the skin cells that make oil. CBC cut back baseline oil production, reduced acne-like oil buildup and calmed inflammation in those cells. The authors said CBC “shows promise” as an anti-acne agent.

CBD has broader skin research overall. But CBC’s sebocyte data is specific, which is why it’s worth a look for skin-focused topicals. Keep in mind that was a lab study on cells, not a trial on people’s skin.